Literature DB >> 34519950

VDR Gene Polymorphisms and Cluster Headache Susceptibility: Case-Control Study in a Southeastern European Caucasian Population.

Maria Papasavva1, Michail Vikelis2, Vasileios Siokas3, Martha-Spyridoula Katsarou1, Emmanouil Dermitzakis4, Athanasios Raptis1, Efthimios Dardiotis3, Nikolaos Drakoulis5.   

Abstract

Cluster headache (CH) is a severe primary headache disorder with a genetic component, as indicated by family and twin studies. Diurnal and seasonal rhythmicity are key features of the disease and might be related to vitamin D, as low vitamin D levels have been observed in patients with cluster headache. In addition, the vitamin D receptor (VDR) occurs in brain areas and particularly in the hypothalamus. The aim of the present case-control study was to investigate the association of cluster headache susceptibility and clinical phenotypes with the VDR gene polymorphisms FokI, BsmI and TaqI in a Southeastern European Caucasian population. DNA was extracted from 131 unrelated CH patients and 282 non-headache controls and genotyped using real-time PCR (melting curve analysis). Linkage disequilibrium (LD) analysis confirmed that BsmI and TaqI, both located in the 3'UTR of the VDR gene, are in strong LD. Genotype and allele frequency distribution analysis of the VDR FokI, BsmI, and TaqI polymorphisms showed no statistically significant difference between cases and controls, whereas haplotype analysis indicated that the TAC haplotype might be associated with decreased cluster headache susceptibility. Intra-patient analysis according to diverse clinical phenotypes showed an association of the BsmI GG and TaqI TT genotypes with more frequent occurrence of CH attacks in this cohort. Therefore, a possible association was observed between VDR gene polymorphisms BsmI and TaqI or a linked locus and susceptibility for cluster headache development and altered clinical phenotypes in the Southeastern European Caucasian study population. Further large-scale replication studies are needed to validate these findings.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  BsmI; FokI; Genetics; Primary headaches; TaqI; Vitamin D receptor

Mesh:

Substances:

Year:  2021        PMID: 34519950     DOI: 10.1007/s12031-021-01892-w

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  42 in total

Review 1.  Vitamin D deficiency accelerates ageing and age-related diseases: a novel hypothesis.

Authors:  Michael J Berridge
Journal:  J Physiol       Date:  2017-10-31       Impact factor: 5.182

2.  Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain.

Authors:  Darryl W Eyles; Steven Smith; Robert Kinobe; Martin Hewison; John J McGrath
Journal:  J Chem Neuroanat       Date:  2005-01       Impact factor: 3.052

3.  Genetics of cluster headache.

Authors:  Kate F Gibson; Anita Dos Santos; Nunu Lund; Rigmor Jensen; Ioannis M Stylianou
Journal:  Cephalalgia       Date:  2019-03-27       Impact factor: 6.292

4.  Vitamin D receptor gene haplotype is associated with late-onset Alzheimer's disease.

Authors:  Duygu Gezen-Ak; Erdinç Dursun; Basar Bilgiç; Hasmet Hanağasi; Turan Ertan; Hakan Gürvit; Murat Emre; Engin Eker; Turgut Ulutin; Omer Uysal; Selma Yilmazer
Journal:  Tohoku J Exp Med       Date:  2012-11       Impact factor: 1.848

Review 5.  Genetic regulation of vitamin D levels.

Authors:  Zari Dastani; Rui Li; Brent Richards
Journal:  Calcif Tissue Int       Date:  2012-11-01       Impact factor: 4.333

6.  GC and VDR SNPs and Vitamin D Levels in Parkinson's Disease: The Relevance to Clinical Features.

Authors:  Duygu Gezen-Ak; Merve Alaylıoğlu; Gençer Genç; Ayşegül Gündüz; Esin Candaş; Başar Bilgiç; İrem L Atasoy; Hülya Apaydın; Güneş Kızıltan; Hakan Gürvit; Haşmet Hanağası; Sibel Ertan; Selma Yılmazer; Erdinç Dursun
Journal:  Neuromolecular Med       Date:  2016-06-09       Impact factor: 3.843

Review 7.  Vitamin D and the brain: Genomic and non-genomic actions.

Authors:  Xiaoying Cui; Helen Gooch; Alice Petty; John J McGrath; Darryl Eyles
Journal:  Mol Cell Endocrinol       Date:  2017-06-01       Impact factor: 4.102

8.  Genetic association of HCRTR2, ADH4 and CLOCK genes with cluster headache: a Chinese population-based case-control study.

Authors:  Zhiliang Fan; Lei Hou; Dongjun Wan; Ran Ao; Dengfa Zhao; Shengyuan Yu
Journal:  J Headache Pain       Date:  2018-01-09       Impact factor: 7.277

9.  Allelic variants in vitamin D receptor gene are associated with adiposity measures in the central-European population.

Authors:  Julie Bienertová-Vašků; Filip Zlámal; Aneta Pohořalá; Ondřej Mikeš; Monika Goldbergová-Pávková; Jan Novák; Zbyněk Šplíchal; Hynek Pikhart
Journal:  BMC Med Genet       Date:  2017-08-22       Impact factor: 2.103

Review 10.  The Neuropharmacology of Cluster Headache and other Trigeminal Autonomic Cephalalgias.

Authors:  Alfredo Costa; Fabio Antonaci; Matteo Cotta Ramusino; Giuseppe Nappi
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

View more
  3 in total

1.  Vitamin D Supplementation and Genetic Polymorphisms Impact on Weight Loss Diet Outcomes in Caucasians: A Randomized Double-Blind Placebo-Controlled Clinical Study.

Authors:  Konstantinos Xenos; Maria Papasavva; Athanasios Raptis; Martha-Spyridoula Katsarou; Nikolaos Drakoulis
Journal:  Front Med (Lausanne)       Date:  2022-03-03

2.  Association of vitamin D receptor gene TaqI polymorphism with Alzheimer's disease in a Southeastern European Caucasian population.

Authors:  Efthimios Dimitrakis; Martha-Spyridoula Katsarou; Maria Lagiou; Vasiliki Papastefanopoulou; Evangelia Stanitsa; Demetrios A Spandidos; Aristidis Tsatsakis; Socratis Papageorgiou; Paraskevi Moutsatsou; Katerina Antoniou; Christos Kroupis; Nikolaos Drakoulis
Journal:  Exp Ther Med       Date:  2022-03-22       Impact factor: 2.447

Review 3.  Deciphering the Role of the rs2651899, rs10166942, and rs11172113 Polymorphisms in Migraine: A Meta-Analysis.

Authors:  Vasileios Siokas; Ioannis Liampas; Athina-Maria Aloizou; Maria Papasavva; Christos Bakirtzis; Eleftherios Lavdas; Panagiotis Liakos; Nikolaos Drakoulis; Dimitrios P Bogdanos; Efthimios Dardiotis
Journal:  Medicina (Kaunas)       Date:  2022-03-29       Impact factor: 2.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.